# Primal Therapies, Inc. — Form D

Primal Therapies, Inc. of BOISE, ID, a company, filed a Form D exempt-offering notice with the SEC on 2016-10-27. The offering totals $1.1M, of which $677K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2016-10-27
- Form: D
- Accession: 0001688401-16-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.1M
- Amount sold: $677K
- Remaining: $400K
- Investors: 8
- Date of first sale: 2016-10-14
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-273343

## Issuer

- Name: Primal Therapies, Inc.
- CIK: 0001688401
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2012
- Address: 9947 WEST EMERALD ST., BOISE, ID, 83704
- Phone: 510-847-8132

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| David Eigen | Director | Southport, CT |
| Terry Fadem | Director | BOISE, ID |
| Emily Stein | Director | BOISE, ID |
| Michael O'Donnell | Executive Officer | Dallas, TX |
| Emily Stein | Executive Officer | BOISE, ID |

## More

- [CIK 1688401 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1688401&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001688401-16-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.